Study of PV in Combination With Bendamustine and Rituximab for Patients With R/R MCL
Study of PV in Combination With Bendamustine and Rituximab for Patients With R/R MCL
Not yet recruiting · NCT04913103 · Registry updated 2021-06-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of PV in Combination With Bendamustine and Rituximab for Patients With R/R MCL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm | Not yet recruiting | Phase 2 | 2021-06-04 | NCT04913103 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Czech Lymphoma Study Group | 4 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Charles University General Hospital | Prague | Czechia | 1 |
| University Hospital Brno | Brno | Czechia | 8 |
| University Hospital Hradec Králové | Hradec Králové | Czechia | 3 |
| University Hospital Kralovske Vinohrady | Prague | Czechia | 4 |
| University Hospital Olomouc | Olomouc | Czechia | 3 |
| University Hospital Ostrava | Ostrava | Czechia | 7 |
| University Hospital Plzeň | Pilsen | Czechia | 1 |